[Top Trade ideas] Jeff Williams is Looking for Momentum to Continue in GFAI

Good morning trader! Here are our top 3 trade ideas today. These setups look primed! Be the best prepared trader on the Street!  👉[MyMD]( Pharmaceuticals, Inc. (MYMD)* — Receives a Grant From European Patent Office For Supera-CBD Compound, trades over 20% 👉Jeff Williams is Looking for Momentum to Continue in GFAI 👉Davis Martin is Looking to trade a Possible Bounce in SPY, Indicators Show It’s in Oversold Territory *This is an Issuer-Paid Advertisement, See Disclosure Below  Sponsored By 👉 [MyMD Pharmaceuticals, Inc. (MYMD)](* — Receives a Grant From European Patent Office For Supera-CBD Compound, trades over 20% [MYMD]( is a clinical-stage pharmaceutical company that develops drug products targeting aging, age-related, and autoimmune diseases. After selling off with the market on Tuesday, [MYMD]( rebounded strongly and was up over 20% at one point yesterday. We explained several times recently that the $3.30 area was a level to watch, due to it being a previous SIGNIFICANT area of support. That proved to be the case as the stock ran as high as $3.93 yesterday. [I Want To Know More About MYMD]( The next major level of resistance forMYMD]( is $4.50 and above that $6. Remember, there was great news for [MYMD](on Tuesday when the company announced they “Received a Grant From European Patent Office For Supera-CBD Compound”. In the PR they said, "We are excited that another major patent office has acknowledged the superior ability of Supera-CBD™ to selectively bind with the CB2 receptor, which could potentially offer a breakthrough drug for the treatment of indications such as pain and anxiety," commented Chris Chapman, M.D., President, Director, and Chief Medical Officer. "This news, along with the ongoing clinical development of lead compound, MYMD-1, demonstrates the continued progress MyMD has made this year in advancing these two products."  Remember, there is a potentially game-changing event for[the company]( upcoming in regards to their Phase 2 study later this year.  [Click Here To FInd Out More About the Company Working to Significantly Increase Lifespan](  *This is an Issuer-Paid Advertisement, See Disclosure Below  Jeff Williams Nails AVCT Jeff has been seeing the market like a Hawk the last couple of days. Yesterday in the 360 newsletter he prepared you to trade AVCT, here’s what we wrote: Jeff likes AVCT here on a rebound play from the high $0.20’s to low $0.30 level with a short term target of $0.40 to $0.45 and a stop at $0.25. Here’s what happened: Here’s how Jeff traded it: Not only does Jeff talk the talk, he walks the walk. This is the type of preparation and analysis you can only get many years of experience. Don’t miss Jeff in the[360 Wall st chatroom](, as he alerts his best trade ideas in real time! [Click here to jump in the 360 Wallstreet chat room](  Jeff Williams is Looking for Momentum to Continue in GFAI Jeff is watching GFAI for a possible run into the mid to high $.40’s today. He loved the breakout yesterday on the daily chart. His stop would be around $.30. Don’t Miss Jeff Williams as He Alerts his trades[LIVE](in the [3]([60 Wall St Chat Room](. He’s already been active today in pre-market! [Here is your direct link to the 360 chat room](  Davis Martin is Looking to trade a Possible Bounce in SPY, Indicators Show It’s in Oversold Territory As I’m typing, SPY’s 60-minute stochastics are extended to the downside and the daily RSI (2) is deeply oversold with a reading of ~5.  Resistance: 393.90, 394, 394.22 Support: 393.80, 393.64, 393.50 In my experience, when the RSI (2) is oversold to this extent, shorts cover and SPY pops - at least for a little bit. I’m going to look for a 3 / 8 EMA crossover to the upside above VWAP to trade SPY Calls. If SPY starts trading around 395 (very close to yesterday’s closing price resistance), I’ll consider today’s audible. [Here is your direct link to the 360 chat room](  62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360.com](  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  *THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID ORWILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Manage your email subscriptions.](